This is a routine investor relations announcement with no material information. Traders should monitor the conference presentations for any updates on SAT-3247 clinical trial progress, particularly the BASECAMP and TRAILHEAD Phase 2 studies, or the planned FSHD IND submission in H2 2026.
Price Chart
Executive Summary
Satellos Bioscience announced management participation in two upcoming investor conferences in September 2026: the Cantor Global Healthcare Conference (Sept 9) and H.C. Wainwright 28th Annual Global Investment Conference (Sept 16). The press release is purely administrative with no new clinical data, financial results, or material corporate developments. The filing is routine and non-material for traders.
Key Facts
- Satellos management will present at the Cantor Global Healthcare Conference on September 9, 2026
- Satellos management will hold a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 16, 2026
- One-on-one investor meetings will be available at both conferences
- No new clinical data, financial results, or material corporate developments were disclosed
Financial Impact
No financial impact from this routine conference participation announcement
Risk Factors
- No new data or catalysts announced; stock may trade on existing pipeline expectations
- Conference participation does not guarantee material disclosures
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (MSLE) — Batch item 1 | 0001171843-26-005825 |
| Document: f6k_083126.htm | 0001171843-26-005825 |
| Document: 0001171843-26-005825-index-headers.html | 0001171843-26-005825 |
| Document: 0001171843-26-005825-index.html | 0001171843-26-005825 |
| Document: 0001171843-26-005825.txt | 0001171843-26-005825 |
| 6-K Filing (MSLE) — Batch item 6 | 0001171843-26-005825 |
| Document: f6k_083126.htm | 0001171843-26-005825 |
| Document: 0001171843-26-005825-index-headers.html | 0001171843-26-005825 |
| Document: 0001171843-26-005825-index.html | 0001171843-26-005825 |
| Document: 0001171843-26-005825.txt | 0001171843-26-005825 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $6.42 | awaiting T+20 | — | $6.88 (+7.17%) |
Oct 21, 2026 6d ago | 6-K | $6.70 | awaiting T+20 | — | $6.88 (+2.69%) |
Oct 5, 2026 22d ago | 6-K | $8.05 | awaiting T+20 | — | $6.88 (−14.53%) |
Sep 30, 2026 27d ago | 6-K | $8.50 | awaiting T+20 | — | $6.88 (−19.06%) |
Sep 30, 2026 27d ago | Press Release | $8.50 | awaiting T+20 | — | $6.88 (−19.06%) |
Sep 24, 2026 4w ago | 6-K | $8.71 $6.63 | ▼ −23.94% | ▼ −23.52% | $6.88 (−21.01%) |
Sep 24, 2026 4w ago | Press Release | $8.71 $6.63 | ▼ −23.94% | ▼ −23.52% | $6.88 (−21.01%) |
Sep 15, 2026 6w ago | 6-K | $9.36 $7.04 | ▼ −24.79% | ▼ −27.51% | $6.88 (−26.50%) |
Sep 9, 2026 6w ago | 6-K | $10.02 $7.63 | ▼ −23.85% | ▼ −26.05% | $6.88 (−31.34%) |
Sep 1, 2026 8w ago | 6-K | $9.08 $8.69 | ▼ −4.30% | ▼ −5.48% | $6.88 (−24.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers